Assessment Of The 12-lead ECG As A Screening Test For CVD In Healthy Young People
Published: September 15, 2014
- Mandatory and universal cardiovascular mass screening with 12-lead ECGs in large general populations of young healthy people 12-25 years of age to identify genetic/congenital and other cardiovascular abnormalities is not recommended for athletes and non-athletes alike.
- Consideration for large-scale, general population and universal cardiovascular screening in the age group 12 to 25 years with history–taking and physical examination alone is not recommended.
- Use by examiners of the AHA 14-point elements and those from other societies as a part of comprehensive history–taking and physical examination to detect or raise suspicion of genetic/congenital and other cardiovascular abnormalities is recommended for cardiovascular screening in young people aged 12 to 25 years.
Supporting Materials
- Commentary: ECG Screening of Youth: Letting Evidence and Reason Prevail by N. A. Mark Estes III, MD
- AHA News: ECGs won’t save more young people, experts say
Recommended Reading
- Science News: Key Concepts in the Evaluation of Screening Approaches for Heart Disease in Children and Adolescents
- Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update
- Science News: AHA/AAP Role of Pulse Oximetry in Examining Newborns for Congenital Heart Disease